Clinical Trial Update: Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating neoadjuvant tipifarnib with docetaxel and capecitabine in adults with locally advanced or metastatic breast cancer and relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer
• Male Breast Cancer
• Stage Iiia Breast Cancer
• Stage Iiib Breast Cancer

Drugs mentioned

• Taxotere (docetaxel)
• Xeloda (capecitabine)
• ZARNESTRA

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Solid Neoplasm, Inflammatory Breast Carcinoma | Phase 1, Phase 2 | Status: COMPLETED